This NDC is on FDA's drug shortage list (posted Apr 7, 2020)
Reported reason: Requirements related to complying with good manufacturing practices
Product Information
FUROSEMIDE 100 MG/10 ML VIAL is a generic product labeled by Accord Healthcare Inc., priced at $0.3417 per ML under NDC 16729050243. Its NADAC has been published 158 times since May 17, 2023.
FDA first approved this application on Dec 15, 1986. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Accord Healthcare Inc.NDC
16729050243
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
5/20/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070017FDA Approved
12/15/1986
TE Code
AP
On Market Since
4/21/2021
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 100 MG/10 ML VIAL has been published 158 times since May 17, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3417 per ML |
|---|---|
| All-time high | $0.5940 (Apr 10, 2024) |
| All-time low | $0.2231 (Jun 18, 2025) |
| 52-week high | $0.3500 |
| 52-week low | $0.2231 |
| Median price | $0.3026 |
| Average price | $0.3274 |
| Largest weekly change | +72.8% (Nov 22, 2023) |
| Weeks tracked | 158 |
| Tracking since | May 17, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
+4.0%
1Y
+53.2%
3Y
-0.6%
5Y
N/A
All
-0.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FUROSEMIDE 100 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 100 MG/10 ML VIAL, manufactured by Accord Healthcare Inc., is $0.3417 per ML (NDC 16729050243), effective May 20, 2026.
How has the price of FUROSEMIDE 100 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 100 MG/10 ML VIAL has held within roughly two percent of its current level. It has been tracked across 158 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 100 MG/10 ML VIAL?
Since May 17, 2023, the NADAC for FUROSEMIDE 100 MG/10 ML VIAL has ranged from a low of $0.2231 (Jun 18, 2025) to a high of $0.5940 (Apr 10, 2024), with a median of $0.3026 per ML.
Are there cheaper alternatives to FUROSEMIDE 100 MG/10 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2658 per ML — about 22% below FUROSEMIDE 100 MG/10 ML VIAL.
Who manufactures FUROSEMIDE 100 MG/10 ML VIAL?
FUROSEMIDE 100 MG/10 ML VIAL (NDC 16729050243) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Is FUROSEMIDE 100 MG/10 ML VIAL in shortage?
Yes — NDC 16729050243 is currently listed in FDA's drug shortage database (posted Apr 7, 2020). Reported reason: Requirements related to complying with good manufacturing practices.